NewBridge Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesDrug Stores & Pharmacies · United Arab Emirates · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Business Central Tower a 18th Floor Shei...Phone Number
+971 44298700Website
www.nbpharma.comRevenue
$20.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About NewBridge Pharmaceuticals
NewBridge Pharmaceuticals is a commercialization platform established in 2010, focused on in-licensing innovative therapies from global pharmaceutical companies. The company aims to bridge the access gap to healthcare in MENA countries, particularly in therapy areas such as gastroenterology, genomics, immunology, neuroscience, oncology/hematology, and rare diseases. Their mission is to save and transform the lives of patients and their families in the region. NewBridge serves a diverse clientele, including healthcare providers and patients across the MENA region.Explore more
NewBridge Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NewBridge Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when NewBridge Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at NewBridge Pharmaceuticals
Earning: See what the market has to say on NewBridge Pharmaceuticals recently announced quarterly report
Check if NewBridge Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once NewBridge Pharmaceuticals has new funding data
NewBridge Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NewBridge Pharmaceuticals is spiking on competitors!
Click to see if NewBridge Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
NewBridge Pharmaceuticals is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
NewBridge Pharmaceuticals is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about NewBridge Pharmaceuticals.
NewBridge Pharmaceuticals financials insights
Gather financial insights about NewBridge Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series B
$12M
NewBridge Pharmaceuticals Tech Stack
A closer look at the technologies used by NewBridge Pharmaceuticals
See more technologies
Most Recent Scoops
Project
, according to a front-line source in artificial intelligence, has completed initiatives related to vulnerability management within the last twelve months.
Information Security, Product Security, Cyber Security, Enterprise Software, Security, Software, Artificial Intelligence
Project
, according to a front-line source in artificial intelligence, is planning to begin initiatives related to communication and collaboration within six to nine months.
Collaboration/Web Apps, Employee Relations, Unified Communications, Artificial Intelligence, Communications
Project
, according to a front-line source in artificial intelligence, is in the midst of initiatives related to application performance monitoring (APM).
Workforce Management, Artificial Intelligence
Project
, according to a front-line source in artificial intelligence, is planning to release a request for proposal (RFP) for initiatives related to microservices within the next six to nine months.
Application Development, Request for Proposal (RFP), Enterprise Architecture, Artificial Intelligence
Project
Request for Proposal (RFP), Data Management, Artificial Intelligence
NewBridge Pharmaceuticals News & Media
BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region
DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its presence and directly manage operations in the MENA region. The collaboration between the two companies began in 2020 and included sales, distribution, and commercialization activities for BRUKINSA® (ZanubrutinBeiGene Announces BRUKINSA™ (zanubrutinib) Is Approved in 50 Markets
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced that its BTK inhibitor BRUKINSA™ (zanubrutinib) has been approved by the Ministry of Health in Kuwait, the National Health Regulatory Authority in Bahrain and the Ministry of Public Health in QatarBeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
CAMBRIDGE, Mass. & BEIJING & DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene and NewBridge Pharmaceuticals announce approval in Saudi Arabia of BRUKINSA® (zanubrutinib) in relapsed or refractory mantle cell lymphoma.Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa
LEIDEN, Netherlands, July 20, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals ("NewBridge") for the distribution of RUCONEST®...
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NewBridge Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NewBridge Pharmaceuticals is a commercialization platform established in 2010, focused on in-licensing innovative therapies from global pharmaceutical companies. The company aims to bridge the access gap to healthcare in MENA countries, particularly in therapy areas such as gastroenterology, genomics, immunology, neuroscience, oncology/hematology,... Read More
